Breaking News

You are here » Indian-Commodity  :  Commodities  :  Crude Oil  :  Crude palm oil futures edge lower on profit-booking

29-Aug2016

Crude palm oil futures edge lower on profit-booking

Crude palm oil futures edged lower on MCX as speculators booked profits at prevailing higher levels amid fall in demand at spot market. Besides, adequate stocks position following higher supply from the producing belts too fuelled the downtrend.

The contract for August delivery was trading at Rs 561.80, down by 0.23% or Rs 1.30 from its previous closing of Rs 563.10. The open interest of the contract stood at 1818.00 lots.

The contract for September delivery was trading at Rs 551.80, down by 0.50% or Rs 2.80 from its previous close of Rs 554.60. The open interest of the contract stood at 3553.00 lots on MCX.


Related News

View all news

Crude oil futures settle lower on renewed global growth fears

Crude oil futures ended lower on Tuesday after a warning from the International Monetary Fund (IMF) and weak economic data out of China underlined concerns about global economic growth and energy demand.......

Crude palm oil futures trade in green on rise in demand

Crude palm oil futures traded in green on MCX in line with the firm  trend in Malaysian palm oil prices. Moreover, rise in spot demand from domestic markets coupled with the worries on dip in......

Crude oil futures trade higher on MCX

Crude oil futures traded higher on MCX, as speculators enlarged positions after data showed refinery processing in China, the world's second-largest oil consumer, climbed to a record in 2018, despite a......

Top News

View all news

RPP Infra Projects bags orders worth Rs 62.90 crore from BHEL

RPP Infra Projects has bagged orders from Bharat Heavy Electricals (BHEL), Chennai for worth of Rs 62.90 crore. The first order is for providing civil works of Boiler, Mill and Bunker, ESP area of unit......

Glenmark gets tentative ANDA approval for Abiraterone Acetate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic......

HDFC Standard Life Insurance reports 18% rise in Q3 net profit

HDFC Standard Life Insurance has reported results for third quarter ended December 31, 2018. The company has reported a rise of 18.48% in its net profit at Rs 245.63 crore for the quarter under review......